In Brief: anti-malaria drugs vs COVID-19, hyp...

A conflict playing out in British Columbia is testing the limits of reconciliation in the province. It’s a fight that involves resource extraction, democracy, political flip-flops, and a test of values. It has set off fears that people may not own their homes and raised the legal ...  Show more

Jayme sits down with Nobel laureate economist, Daron Acemoglu, a professor at MIT, and one of the leading thinkers about labour, politics and technology. He’s the author of the best-selling book “Why Nations Fail” and the forthcoming work “What Happened to Liberal Democracy?”. Th ...  Show more

Despite the FDA’s warning of serious side effects from taking hydroxychloroquine, the President of the United States has defended his decision to take the drug. David Holtgrave, a lead researcher in a hydroxychloroquine study, tells Anderson Cooper in their study they didn’t find ...  Show more

In this Journal Jam podcast we dig deep into the science of FDA-approved outpatient medications for COVID with 3 critical appraisal masters: Dr. Andrew Morris, Dr. Rohit Mohindra and Dr. Justin Morgenstern. What is the evidence for the neutralizing monoclonal antibody medications ...  Show more

As medical professionals search for new treatments to help Covid-19 patients, some researchers are taking a second look at drugs that have already been approved by the FDA. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to Dr. David Fajgenbaum about repurposing old drugs ...  Show more

The U.S. Food and Drug Administration has authorized the emergency use of convalescent plasma to help treat patients with Covid-19 saying the “known and potential benefits of the product outweigh the known and potential risks of the product.” President Trump claimed “political re ...  Show more